Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-18

Clinical Trial Update: Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating etoricoxib for chronic recurrent low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etoricoxib (etoricoxib)

Snippet

Sponsor: Organon and Co | Conditions: Recurrent Low Back Pain | Phase 3 | Status: COMPLETED